Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiang-Sha-Liu-Jun-Zi-Tang in IBS
NCT02179580Phase 3Unknown
- Sponsor
- China Medical University Hospital
- Start
- Jun 2014
- Primary completion
- Dec 2015
- Modality
- HM (Herbal Medicine), Dietary Supplement, NPI (Non-Pharmacological Intervention)
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing Xiang-Sha-Liu-Jun-Zi-Tang with Placebo (2 arms). Primary endpoint: Gastrointestinal System Rating Scale-IBS Questionnaire at 12 weeks. Status: unknown.
02
Drugs
Xiang Sha Liu Jun Zi Decoction
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02179580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02179580.